Fear of hypoglycemia in people with diabetes
Official title: THE EFFECT OF FEAR OF HYPOGLYCEMIA ON DIET AND MEDICATION ADHERENCE IN PATIENTS WITH DIABETES
Run by Bilecik Seyh Edebali Universitesi · NCT07329985 · Data updated 2026-11-12
This study looks at how fear of low blood sugar affects how people with diabetes take their medications and manage their diet.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Bilecik Seyh Edebali Universitesi Academic / other |
| Locations | 1 site (Bilecik) |
| Status | Recruiting |
| Started | April 15, 2026 |
| Main results expected | January 15, 2027 |
| Study ends | March 15, 2027 |
| Registry record updated | September 16, 2026 |
| Trial ID | NCT07329985 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with diagnosed diabetes who have experienced at least one hypoglycemic event and are using antidiabetic medications.
✕Probably not a fit
Patients who do not experience fear-related adherence issues or who do not have a history of hypoglycemia may see limited benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study explores how fear of hypoglycemia influences medication adherence, dietary choices, and self-management in adults with diabetes. It notes that both too little and too much fear can worsen glycemic control and quality of life, potentially increasing long-term complication risk. The study emphasizes that psychosocial factors should be considered alongside biochemical monitoring in diabetes care. Data collection will focus on patient experiences, behaviors, and self-management practices in relation to hypoglycemia fear.
Why it matters
Potential benefit: If successful, findings could guide healthcare providers to address fear of hypoglycemia and improve adherence and metabolic control.
How similar studies have gone: Previous research indicates fear of hypoglycemia can influence adherence and self-management, suggesting this area is clinically relevant but may have variable effects across populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Diagnosed with diabetes Aged 18-65 Having experienced at least one hypoglycemic attack previously, Using antidiabetic medication (oral pills and/or insulin), Volunteered to participate in the study Exclusion Criteria: unable to communicate in the same language having cognitive impairment wanting to leave the study at any stage
Where it's running
-
Bilecik Eğitim ve Araştırma Hastanesi
Bilecik, Turkey (Türkiye) Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
What personal, social, and access factors affect taking diabetes medicines
This project will see if patients' knowledge, beliefs, family support, healthcare communication, and access problems influence how adults with diabetes take their medicines.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
Understanding glucagon and sugar metabolism after meals in people with and without PBH after weight-loss surgery
This study tests how glucagon and post-meal glucose handling differ between people who have post-bariatric surgery hypoglycemia and those who don’t.
-
DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes
This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.